Showing results (251-260 of 255) with videos related to
Sort By:
Pageof 26
You have reached the last page of results.This site can display upto 255 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2015
Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled TrialStefan S Bielack, Sigbjørn Smeland, Jeremy S Whelan, et al.European Journal of Cancer (Oxford, England : 1990)|January 28, 2019
Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohortSigbjørn Smeland, Stefan S Bielack, Jeremy Whelan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2019
Functional Repair Assay for the Diagnosis of Constitutional Mismatch Repair Deficiency From Non-Neoplastic TissueAndrew Y Shuen, Stella Lanni, Gagan B Panigrahi, et al.Nature Communications|February 13, 2021
PRMT5 inhibition disrupts splicing and stemness in glioblastomaPatty Sachamitr, Jolene C Ho, Felipe E Ciamponi, et al.The Lancet. Oncology|August 30, 2016
Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trialNeyssa M Marina, Sigbjørn Smeland, Stefan S Bielack, et al.Pageof 26